The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog (insulin aspart), for treating adults and children with diabetes.
International Approvals, May 01, 2019 Alert FDA OKs Second Etanercept Biosimilar for Inflammatory Diseases Etanercept-ykro (Eticovo) is approved across all eligible indications for rheumatoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback